Given a 500 mL bag of 10% dextrose solution, how many units of Actrapid (regular insulin) should be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Dosing for 10% Dextrose Solution

Add 10 units of Actrapid (regular insulin) to your 500 mL bag of 10% dextrose solution.

Rationale and Dosing Algorithm

Your 500 mL bag of 10% dextrose contains 50 grams of glucose (10 g per 100 mL × 500 mL = 50 g total). The standard approach is to provide approximately 1 unit of insulin for every 4-5 grams of glucose to prevent hyperglycemia while maintaining adequate glucose delivery.

Standard Insulin-to-Glucose Ratio

  • 50 grams of dextrose requires 10 units of regular insulin 1
  • This represents the most commonly studied and guideline-supported ratio in clinical practice
  • Alternative dosing of 5 units with 25 g dextrose exists, but your bag contains 50 g 2

Clinical Context Matters

If treating hyperkalemia:

  • 10 units IV regular insulin with 50 g dextrose is the established regimen 1
  • Monitor blood glucose hourly for 4-6 hours post-administration 3
  • Hypoglycemia risk is approximately 22% with standard 10 units + 25 g regimen 4, but increases to 50 g dextrose reduces this risk

If managing diabetic ketoacidosis (DKA):

  • This is NOT the appropriate formulation - DKA requires separate fixed-rate insulin infusion protocols 5
  • Do not use premixed insulin-dextrose bags for DKA management

Critical Safety Considerations

High-Risk Populations for Hypoglycemia

Monitor more frequently (every 1-2 hours) if patient has 3, 4:

  • Renal impairment (90% of hypoglycemia cases had kidney dysfunction) 2
  • Female gender
  • Lower body weight
  • Baseline glucose <110 mg/dL
  • No diabetes history

Dose Modifications

Consider reducing to 5 units of insulin if:

  • Patient weight <50 kg
  • Baseline glucose <100 mg/dL
  • Severe renal impairment (CrCl <30 mL/min)
  • However, you would then need only 25 g dextrose, not your full 500 mL bag

Do NOT exceed 10 units for this volume - higher doses (20 units) require 60 g dextrose and show no additional potassium-lowering benefit while significantly increasing hypoglycemia risk 1

Administration Technique

  • Add the 10 units of Actrapid directly to the 500 mL bag
  • Administer as continuous infusion over 60 minutes (not as bolus) 1
  • This provides more stable glucose levels compared to rapid bolus administration
  • Begin glucose monitoring before infusion starts and continue hourly for minimum 6 hours 6

Common Pitfalls to Avoid

  1. Do not use sliding scale insulin alone - this is condemned in guidelines and leads to poor glycemic control 5
  2. Do not give insulin without adequate dextrose - the 1:5 ratio (units:grams) is critical for safety
  3. Do not assume monitoring can stop after 2-3 hours - insulin's duration of action exceeds dextrose, requiring extended surveillance 3
  4. Do not use 50% dextrose concentration - 10% dextrose in larger volumes provides more controlled glucose delivery and avoids overcorrection 7

The 10 units in 500 mL of 10% dextrose represents the evidence-based standard that balances efficacy with safety across multiple clinical indications 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.